| Literature DB >> 26084830 |
Marta Fernandez-Sampedro1, Carlos Salas-Venero2, Concepción Fariñas-Álvarez3, Manuel Sumillera4, Luis Pérez-Carro5, Michel Fakkas-Fernandez6, Javier Gómez-Román7, Luis Martínez-Martínez8, María Carmen Fariñas9.
Abstract
BACKGROUND: The most common cause of implant failure is aseptic loosening (AL), followed by prosthetic joint infection (PJI). This study evaluates the incidence of PJI among patients operated with suspected AL and whether the diagnosis of PJI was predictive of subsequent implant failure including re-infection, at 2 years of follow up.Entities:
Mesh:
Year: 2015 PMID: 26084830 PMCID: PMC4470055 DOI: 10.1186/s12879-015-0976-y
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Fig. 1Distribution of study patients. a One out of 2 cases received antibiotic therapy post-revision arthroplasty. b One out of 3 cases received antibiotic therapy post-revision arthroplasty. c Received antibiotic therapy post-revision arthroplasty
Demographic and clinical characteristics of study patients
| Characteristic | Aseptic loosening ( | PJI ( |
|
|---|---|---|---|
| Age (year)-mean (SD) | 69.5 (12.0) | 68.2 (14.1) | 0.61 |
| Gender- no. (%) | |||
| Male | 72 (41.4) | 14 (58.3) | 0.13 |
| Body mass index-mean (SD) | 30.8 (4.8) | 30.6 (6.1) | 0.84 |
| Location | |||
| Hip | 118(67.8) | 23(95.8) | 0.003 |
| Knee | 56 (32.2) | 1(4.2) | |
| Surgical procedure-no. (%)a | |||
| Partial Revision | 99 (56.9) | 19 (79.1) | 0.045 |
| Total Revision (One-stage exchange) | 73 (42.0) | 4 (16.7) | |
| Two-stage revision | 1 (0.6) | 0 | |
| Girdlestone | 1 (0.6) | 1(4.2) | |
| Underlying joint disorder-no (%) | |||
| Osteoarthritis | 6 (3.4) | 0 | 1.00 |
| Osteoarthrosis | 14 (8.0) | 4 (16.7) | 0.24 |
| Osteoporosis | 19 (10.9) | 4 (16.7) | 0.49 |
| Rheumatoid arthritis | 7 (4.0) | 0 | 1.00 |
| Acute fracture/trauma | 9 (5.2) | 1(4.2) | 1.00 |
| Malignancy | 3 (1.7) | 0 | 1.00 |
| Associated conditions- no. (%) | |||
| Diabetes mellitus | 25 (14.4) | 5 (20.8) | 0.38 |
| Immunosuppressive therapy | 6 (3.4) | 0 | 1.00 |
| Systemic steroid therapy | 6 (3.4) | 0 | 1.00 |
| Prior revision arthroplasty | 34 (19.5) | 8 (33.3) | 0.18 |
| Time between last implantation and removal of implant-no. (%) | |||
| ≤30 days | 1 (0.6) | 1 (4.2) | 0.12 |
| 31– 365 days | 15 (8.6) | 5 (20.8) | |
| 366 days-5 years | 51 (29.3) | 6 (25.0) | |
| 6-10 years | 32 (18.4) | 5 (20.8) | |
| 11-15 years | 31 (17.8) | 5 (20.8) | |
| >15 years | 44 (25.3) | 2 (8.3) | |
| Blood units after surgery-no. (%) | 32 (18.4) | 8 (33.3) | 0.11 |
| Length of surgery (minutes)- | 152.6 (70.7) | 173.8 (93.9) | 0.20392 |
| Mean (SD) | 393 |
PJI Prosthetic joint infection; SD Standard Deviation
aTwo-tailed Chi-squared or Fisher exact test for categorical variables or t-test for continuous variables
Microbiology results in 21 patients with definitive PJI and positive cultures
| Case | Peri-implant tissue | Tissue culture-number positive/submitted | Sonicate fluid (>20 CFU) | Colony forming units | Histopathology |
|---|---|---|---|---|---|
| 1 |
| 1/4 |
| 5 | + |
| 2 |
| 3/3 |
| >100 | + |
| 3 |
| 2/3 |
| >100 | + |
| 4 |
| 3/4 |
| >100 | _ |
| 5 |
| 2/3 |
| >100 | _ |
| 6 |
| 2/4 |
| >100 | + |
| 7 |
| 2/3 |
| >100 | _ |
| 8 |
| 3/3 |
| >100 | _ |
| 9 |
| 3/3 |
| >100 | _ |
| 10 |
| 3/3 |
| >100 | _ |
|
|
| >100 | |||
| 11 |
| 2/3 |
| >100 | + |
| 12 |
| 3/3 |
| 60 | _ |
| 13 |
| 2/3 |
| >100 | _ |
| 14 |
| 2/2 |
| >100 | + |
| 15 |
| 4/4 |
| >100 | + |
| 16 |
| 3/3 |
| >100 | + |
| 17 | -- | 0/3 |
| >100 | + |
| 18 | -- | 1/3 |
| >100 | + |
| 19 | -- | 0/3 |
| >100 | + |
| 20 | -- | 0/3 |
| 55 | + |
| 21 | -- | 0/4 |
| >100 | + |
PJI Prosthetic joint infection, CFU Colony-forming unit